G-Proteins: implications for pathophysiology and disease
Gordeladze JO, Johansen PW, Paulssen RH, Paulssen EJ, Gautvik KM. G-Proteins: implications for pathophysiology and disease. Eur J Endocrinol 1994;131:557–74. ISSN 0804–4643 This article focuses on the involvement of G-proteins in neuroendocrine secretion, cell growth and phenotype alterations. The current concept of hormonal activation of the GTPase cycle, as well as the molecular diversity of G-protein families and receptor * G-protein * effector coupling, are described. Also described are certain G-proteins as possible proto-oncogenes and how point mutations and frame shift mutations alter G-protein function and determine the characteristics of various endocrine diseases. The article outlines in detail how receptors and G-proteins interact in prolactin and growth-hormone-secreting pituicytes, how G-proteins are involved in the growth and differentiation of preadipocytes and osteoblasts. All in all, it seems that hormonal activation through G-proteins is modulated through direct intra- and inter-signalling system cross-talk at the plasma membrane level (short-term) and through interactions on the level of transcription (HREs) from tyrosine kinases, steroid-like hormones and metabolic pathways. Pharmacological intervention to treat diseases where G-proteins are involved should take both long and short-term regulatory phenomena into consideration. JO Gordeladze, Institute of Medical Biochemistry, University of Oslo, PO Box 1112, Blindern, 0317 Oslo, Norway